These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18091432)

  • 21. Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response.
    Min W; Li T; Ma X; Li Z; Yu T; Gao D; Zhang B; Yun Y; Sun X
    Psychopharmacology (Berl); 2009 Aug; 205(3):409-17. PubMed ID: 19468717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy.
    Strawn JR; Mills JA; Croarkin PE
    J Child Adolesc Psychopharmacol; 2019 May; 29(4):250-255. PubMed ID: 30810350
    [No Abstract]   [Full Text] [Related]  

  • 23. Cytochrome P450 genotype and aggressive behavior on selective serotonin reuptake inhibitors.
    Ekhart C; Matic M; Kant A; Elens L; Puijenbroek EV; Schaik RV
    Pharmacogenomics; 2018 Sep; 19(14):1097-1099. PubMed ID: 30165797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does adding noradrenaline reuptake inhibition to selective serotonin reuptake inhibition improve efficacy in patients with depression? A systematic review of meta-analyses and large randomised pragmatic trials.
    Bradley AJ; Lenox-Smith AJ
    J Psychopharmacol; 2013 Aug; 27(8):740-58. PubMed ID: 23832963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharamacogenetics and antidepressant treatment in integrative psychiatry perspective.
    Mihaljević-Peles A; Sagud M; Bozina N; Zivković M
    Psychiatr Danub; 2008 Sep; 20(3):399-401. PubMed ID: 18827770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guidelines for treating depression using non-selective serotonin reuptake inhibitors.
    Withersty DJ; Vanin JR
    W V Med J; 1999; 95(1):20-3. PubMed ID: 9949692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Citalopram in the treatment of depression.
    Parker NG; Brown CS
    Ann Pharmacother; 2000 Jun; 34(6):761-71. PubMed ID: 10860138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients.
    Alexopoulos GS; Katz IR; Reynolds CF; Carpenter D; Docherty JP;
    Postgrad Med; 2001 Oct; Spec No Pharmacotherapy():1-86. PubMed ID: 17205639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis.
    MacGillivray S; Arroll B; Hatcher S; Ogston S; Reid I; Sullivan F; Williams B; Crombie I
    BMJ; 2003 May; 326(7397):1014. PubMed ID: 12742924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical effectiveness and cost-effectiveness of testing for cytochrome P450 polymorphisms in patients with schizophrenia treated with antipsychotics: a systematic review and economic evaluation.
    Fleeman N; McLeod C; Bagust A; Beale S; Boland A; Dundar Y; Jorgensen A; Payne K; Pirmohamed M; Pushpakom S; Walley T; de Warren-Penny P; Dickson R
    Health Technol Assess; 2010 Jan; 14(3):1-157, iii. PubMed ID: 20031087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The usefulness of genotyping cytochrome P450 enzymes in the treatment of depression.
    Dubovsky SL
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):369-79. PubMed ID: 25554071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The influence of genetic variations on the effect of selective serotonin reuptake inhibitors].
    Bukh JO; Bock C; Mors NP; Kessing LV
    Ugeskr Laeger; 2007 Apr; 169(16):1439-41. PubMed ID: 17484840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic interactions of selective serotonin reuptake inhibitors with other commonly prescribed drugs in the era of pharmacogenomics.
    Manolopoulos VG; Ragia G; Alevizopoulos G
    Drug Metabol Drug Interact; 2012 Feb; 27(1):19-31. PubMed ID: 22718622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders.
    Nutt DJ; Forshall S; Bell C; Rich A; Sandford J; Nash J; Argyropoulos S
    Eur Neuropsychopharmacol; 1999 Jul; 9 Suppl 3():S81-6. PubMed ID: 10523062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Female sexual dysfunction in patients with major depressive disorder (MDD) treated with selective serotonin reuptake inhibitor (SSRI) and its association with serotonin 2A-1438 G/A single nucleotide polymorphisms.
    Masiran R; Sidi H; Mohamed Z; Mohd Nazree NE; Nik Jaafar NR; Midin M; Das S; Mohamed Saini S
    J Sex Med; 2014 Apr; 11(4):1047-1055. PubMed ID: 24533444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity.
    Cusin C; Serretti A; Zanardi R; Lattuada E; Rossini D; Lilli R; Lorenzi C; Smeraldi E
    Int J Neuropsychopharmacol; 2002 Mar; 5(1):27-35. PubMed ID: 12057029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonin transporter gene polymorphism and antidepressant response.
    Kim DK; Lim SW; Lee S; Sohn SE; Kim S; Hahn CG; Carroll BJ
    Neuroreport; 2000 Jan; 11(1):215-9. PubMed ID: 10683861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does pretreatment testing for serotonin transporter polymorphisms lead to earlier effects of drug treatment in patients with major depression? A decision-analytic model.
    Smits KM; Smits LJ; Schouten JS; Peeters FP; Prins MH
    Clin Ther; 2007 Apr; 29(4):691-702. PubMed ID: 17617292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenetics of antidepressant treatment in obsessive-compulsive disorder: an update and implications for clinicians.
    Zai G; Brandl EJ; Müller DJ; Richter MA; Kennedy JL
    Pharmacogenomics; 2014 Jun; 15(8):1147-57. PubMed ID: 25084207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.